Details for Patent: 7,846,961
✉ Email this page to a colleague
Which drugs does patent 7,846,961 protect, and when does it expire?
Patent 7,846,961 protects PRESTALIA and is included in one NDA.
This patent has thirty patent family members in twenty-seven countries.
Summary for Patent: 7,846,961
| Title: | .alpha. crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it |
| Abstract: | .alpha.-crystalline form of the compound of formula (I): ##STR00001## characterized by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme. |
| Inventor(s): | Coquerel; Gerard (Boos, FR), Lefebvre; Loic (Mont Saint Aignan, FR), Souvie; Jean-Claude (Pau, FR), Authouart; Pascale (Les Trois Pierres, FR) |
| Assignee: | Les Laboratoires Servier (Suresnes Cedex, FR) |
| Application Number: | 12/224,369 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,846,961 |
|
Patent Claim Types: see list of patent claims | Compound; Process; Composition; Use; |
Drugs Protected by US Patent 7,846,961
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adhera | PRESTALIA | amlodipine besylate; perindopril arginine | TABLET;ORAL | 205003-001 | Jan 21, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF HYPERTENSION | ⤷ Sign Up | ||
| Adhera | PRESTALIA | amlodipine besylate; perindopril arginine | TABLET;ORAL | 205003-002 | Jan 21, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF HYPERTENSION | ⤷ Sign Up | ||
| Adhera | PRESTALIA | amlodipine besylate; perindopril arginine | TABLET;ORAL | 205003-003 | Jan 21, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF HYPERTENSION | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,846,961
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 06 01748 | Feb 28, 2006 |
| PCT Information | |||
| PCT Filed | February 26, 2007 | PCT Application Number: | PCT/FR2007/000335 |
| PCT Publication Date: | September 07, 2007 | PCT Publication Number: | WO2007/099217 |
International Family Members for US Patent 7,846,961
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007220435 | ⤷ Sign Up | |||
| Brazil | PI0708278 | ⤷ Sign Up | |||
| Canada | 2644467 | ⤷ Sign Up | |||
| China | 101389603 | ⤷ Sign Up | |||
| Cyprus | 1117753 | ⤷ Sign Up | |||
| Denmark | 1989182 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
